Dutch Life Science Database

- Ortho's new SARS-CoV-2 antigen test offers 98.9% concordance[i] to real-time PCR tests, making it a viable alternative suitable for mass-scale testing

By: PR Newswire Association LLC. - 02 Nov 2020

Sanofi offers to acquire Kiadis for €308 million

By: GlobenewsWire - 02 Nov 2020

Related companies: Kiadis Pharma N.V.

Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over Humira® in Moderate-to-Severe Psoriasis Patients

BRUSSELS, Oct. 31, 2020 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced the detailed results of the head-to-head Phase 3 BE SURE study, which demonstrated that patients treated with investigational IL-17A and IL-17F inhibitor bimekizumab achieved superior skin clearance,... Read more ››

By: PR Newswire Association LLC. - 31 Oct 2020

Novo Nordisk's operating profit increased by 6% in Danish kroner and by 7% at constant exchange rates (CER) in the first nine months of 2020

By: GlobenewsWire - 30 Oct 2020

European Patent Office rules in favor of Sanofi and Regeneron concerning Praluent® (alirocumab)

By: GlobenewsWire - 29 Oct 2020

Sensus Healthcare to Host Third Quarter 2020 Financial Results and Business Update Conference Call on November 5, 2020

By: GlobenewsWire - 29 Oct 2020

Related companies: Sensus

UCB Presents Nine Abstracts at EADV 2020, Showcasing Ongoing Commitment to Dermatology

BRUSSELS, Oct. 29, 2020 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that new data on the investigational IL-17A and IL-17F inhibitor, bimekizumab, and TNF inhibitor, CIMZIA(® )(certolizumab pegol), in the management of moderate-to-severe plaque psoriasis are being... Read more ››

By: PR Newswire Association LLC. - 29 Oct 2020

Sanofi Q3 2020 business EPS(1) growth of 8.8% at CER

By: GlobenewsWire - 29 Oct 2020

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 29 Oct 2020

Sanofi to evaluate the safety and efficacy of novel investigational candidate THOR-707 and KEYTRUDA® (pembrolizumab) in pursuit of establishing a new treatment option in oncology

By: GlobenewsWire - 29 Oct 2020

Pharming Group reports financial results for the first nine months of 2020

Continued solid performance and strong recovery of sales in Q3 2020

By: PR Newswire Association LLC. - 29 Oct 2020

Related companies: Pharming Group NV

Pharming convenes Extraordinary General Meeting of shareholders

LEIDEN, Netherlands, Oct. 29, 2020 /PRNewswire/ -- Pharming Group N.V. (Euronext Amsterdam: PHARM) today announces it will hold an Extraordinary General Meeting (EGM) of Shareholders on Friday 11 December 2020 at 14:00 CET.

By: PR Newswire Association LLC. - 29 Oct 2020

Related companies: Pharming Group NV

Sanofi and GSK to support COVAX with 200 million doses of adjuvanted, recombinant protein-based COVID-19 vaccine

By: GlobenewsWire - 28 Oct 2020

Sanofi: Information concerning the total number of voting rights and shares - September 2020

By: GlobenewsWire - 27 Oct 2020

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 »

Looking for companies outside of Netherlands?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

April 2021
- NLSDays + NLS Invest Digital - Nordic Life Science Days
- 4th Annual Neuroscience Innovation Forum
May 2021
- Biotechgate Digital Partnering

See Events »

Add an Event »

Latest company news

ProQR Announces Participation in Upcoming Kempen Life Sciences Conference
22 Apr 2021 (GlobenewsWire)

Pharming announces enrolment of first patient in multicentre Phase IIb clinical trial of RUCONEST® for the prevention of acute kidney injury after myocardial infarction
22 Apr 2021 (PR Newswire Association LLC.)

MDxHealth announces listing of 9,639,489 existing shares on Euronext Brussels following the January 2021 Capital Increase
21 Apr 2021 (GlobenewsWire)

News in the Life Sciences Industry

Looking for companies outside of Netherlands?

Partners

Upcoming Life Sciences Events

Latest company news